Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent.

Autophagy has been recognized as a potential target for cancer therapy. The antimalarial drug chloroquine (CQ) is able to inhibit autophagy and therefore is being considered for cancer therapeutics. However, the relatively low potency of CQ prompted us to investigate whether other lysosomotropic agents might be more effective, and thus potentially more useful. We therefore compared the cytotoxic efficacy of CQ, the quinoline analog mefloquine (MQ), and the fluoroquinolones ciprofloxacin and levofloxacin in several human breast cancer cell lines. We found that MQ was the most potent compound tested; it inhibited autophagy, triggered endoplasmic reticulum stress, and caused cell death in T47D and MDA-MB-231. Altogether, our study demonstrates superior potency of MQ over CQ and the ability of MQ to produce anticancer effects in both hormone receptor positive and negative breast cancer cell lines, suggesting its usefulness in treating various types of cancer.

[1]  R. Kurzrock,et al.  Autophagy as a target for anticancer therapy , 2011, Nature Reviews Clinical Oncology.

[2]  Philippe Lambin,et al.  The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5. , 2010, The Journal of clinical investigation.

[3]  P. Morlière,et al.  Lysosomes Are Sites of Fluoroquinolone Photosensitization in Human Skin Fibroblasts: A Microspectrofluorometric Approach* , 1999, Photochemistry and photobiology.

[4]  J. Sotelo,et al.  Adding Chloroquine to Conventional Treatment for Glioblastoma Multiforme , 2006, Annals of Internal Medicine.

[5]  Ye Xu,et al.  p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins. , 2011, European journal of cancer.

[6]  S. McKenna,et al.  Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics. , 2011 .

[7]  Kevin A Roth,et al.  Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent. , 2010, Neuro-oncology.

[8]  Thomas C. Chen,et al.  Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors. , 2012, Cancer letters.

[9]  R. Fass.  Ciprofloxacin. Best use of this new broad-spectrum antibiotic. , 1990, Postgraduate medicine.

[10]  G. Dow,et al.  The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro , 2003, Malaria Journal.

[11]  H. Stenmark,et al.  p62, an autophagy hero or culprit? , 2010, Nature Cell Biology.

[12]  P. Morlière,et al.  Damage to mitochondria of cultured human skin fibroblasts photosensitized by fluoroquinolones. , 2000, Journal of photochemistry and photobiology. B, Biology.

[13]  P. Jaakkola,et al.  p62 degradation by autophagy: Another way for cancer cells to survive under hypoxia , 2009, Autophagy.

[14]  G. Kroemer,et al.  Lysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion , 2003, The Journal of experimental medicine.

[15]  H. Coller,et al.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. , 2011, Genes & development.

[16]  K. Sasaki,et al.  Enhancement of doxorubicin activity in multidrug-resistant cells by mefloquine. , 2000, Methods and findings in experimental and clinical pharmacology.

[17]  Huiqing Yuan,et al.  Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. , 2011, Cancer letters.

[18]  A. Thorburn,et al.  Autophagy in cancer: good, bad, or both? , 2006, Cancer research.

[19]  K. Rantanen,et al.  Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62 , 2009, Oncogene.

[20]  P. Codogno,et al.  Canonical and non-canonical autophagy: variations on a common theme of self-eating? , 2011, Nature Reviews Molecular Cell Biology.

[21]  N. Myeku,et al.  Dynamics of the Degradation of Ubiquitinated Proteins by Proteasomes and Autophagy , 2011, The Journal of Biological Chemistry.

[22]  Raymond Sawaya,et al.  The role of autophagy in cancer development and response to therapy , 2005, Nature Reviews Cancer.

[23]  H. Glaumann,et al.  Intracellular distribution and effect of the antimalarial drug mefloquine on lysosomes of rat liver. , 2008, Liver.

[24]  G. Dow,et al.  Effect of sample size and P-value filtering techniques on the detection of transcriptional changes induced in rat neuroblastoma (NG108) cells by mefloquine , 2003, Malaria Journal.

[25]  B. Foleno,et al.  In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin , 1992, Antimicrobial Agents and Chemotherapy.

[26]  Sung-Hoon Kim,et al.  Pentagalloylglucose induces autophagy and caspase-independent programmed deaths in human PC-3 and mouse TRAMP-C2 prostate cancer cells , 2009, Molecular Cancer Therapeutics.

[27]  H. Nagawa,et al.  Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells , 2010, BMC Cancer.

[28]  S. Hladky,et al.  Interactions of mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red cell membranes. , 2005, Biochemical pharmacology.

[29]  D. Stolz,et al.  Differential Effects of Endoplasmic Reticulum Stress-induced Autophagy on Cell Survival* , 2007, Journal of Biological Chemistry.

[30]  D. Harder,et al.  Hydrogen peroxide induces nitric oxide and proteosome activity in endothelial cells: a bell-shaped signaling response. , 2007, Free radical biology & medicine.

[31]  G. Salvesen,et al.  Caspases: Intracellular Signaling by Proteolysis , 1997, Cell.

[32]  A. Schönthal,et al.  Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress. , 2009, Cancer letters.

[33]  H. Kim,et al.  Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  P. Dayton,et al.  Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090. , 1975, Drug metabolism and disposition: the biological fate of chemicals.

[35]  D. Rubinsztein,et al.  Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates , 2009, Molecular cell.

[36]  S. Pervaiz,et al.  Simultaneous Induction of Non-Canonical Autophagy and Apoptosis in Cancer Cells by ROS-Dependent ERK and JNK Activation , 2010, PloS one.

[37]  D. Lev,et al.  Autophagy blockade enhances HDAC inhibitors’ pro-apoptotic effects , 2011, Autophagy.

[38]  Ming-Shiang Wu,et al.  Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. , 2010, Cancer research.

[39]  E. White,et al.  The Double-Edged Sword of Autophagy Modulation in Cancer , 2009, Clinical Cancer Research.

[40]  G. Evan,et al.  Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. , 2007, The Journal of clinical investigation.

[41]  Zhining Wang,et al.  Transcriptional profiling of mefloquine-induced disruption of calcium homeostasis in neurons in vitro. , 2005, Genomics.

[42]  P. Codogno,et al.  Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells , 2008, Cell Death and Differentiation.

[43]  Seamus J. Martin,et al.  Oncogenic Ras-induced expression of Noxa and Beclin-1 promotes autophagic cell death and limits clonogenic survival. , 2011, Molecular cell.

[44]  Hans Clevers,et al.  Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines , 2010, Breast Cancer Research and Treatment.

[45]  Baoqing Guo,et al.  Cross-Resistance Studies of Isogenic Drug-Resistant Breast Tumor Cell Lines Support Recent Clinical Evidence Suggesting that Sensitivity to Paclitaxel may be Strongly Compromised by Prior Doxorubicin Exposure , 2004, Breast Cancer Research and Treatment.

[46]  A. Cowman,et al.  Modulation of the function of human MDR1 P-glycoprotein by the antimalarial drug mefloquine. , 1996, Biochemical pharmacology.

[47]  R. Kaufman,et al.  Adaptation to ER Stress Is Mediated by Differential Stabilities of Pro-Survival and Pro-Apoptotic mRNAs and Proteins , 2006, PLoS biology.

[48]  F. André,et al.  Triple-negative breast cancer: are we making headway at least? , 2012, Therapeutic advances in medical oncology.

[49]  A. Schönthal.  Endoplasmic reticulum stress and autophagy as targets for cancer therapy. , 2009, Cancer letters.

[50]  William A Weiss,et al.  Principles and Current Strategies for Targeting Autophagy for Cancer Treatment , 2011, Clinical Cancer Research.

[51]  Thomas C. Chen,et al.  Antiangiogenic Activities of 2,5-Dimethyl-Celecoxib on the Tumor Vasculature , 2010, Molecular Cancer Therapeutics.

[52]  Marc Liesa,et al.  Pancreatic cancers require autophagy for tumor growth. , 2011, Genes & development.

[53]  A. Sapino,et al.  HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast , 2012, BMC Cancer.

[54]  L. Rhodes,et al.  Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat , 2012, Breast Cancer Research.

[55]  Thomas C. Chen,et al.  Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. , 2009, Blood.

[56]  A. Schönthal,et al.  COX-2 inhibition is neither necessary nor sufficient for celecoxib to suppress tumor cell proliferation and focus formation in vitro , 2008, Molecular Cancer.